MedPath

A prospective randomised controlled study to evaluate ankle dorsiflexion after cast immobiliation and percutaneous gastrocnemius lengthening, for neurologic healthy children (6-18) with an symptomatic equinus contracture.

Withdrawn
Conditions
equinus contracture
short achilles tendon
10028396
Registration Number
NL-OMON38124
Lead Sponsor
Spaarne Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Patients (boys and girls) between 6-18 years
independent walking achieved
symptomatic limited ankle dorsi flexion between -10 and 3 degrees (with knee in extension and ankle in neutral position)
patient has been treated non-surgically for at least 6 month (NSAIDs, stretching, orthoses and physical therapy)
Written informed consent both parents/ guardian (children 6-12 years)
written informed consent both parents/ guardian and child (children 12-18 years)

Exclusion Criteria

Patients with signs of neurological, orthopaedic or psychiatric disease.
Patients with mental retardation
Patients with previous surgery on the ankle
Patients who were already treated with castimmobilisation because of equinus contracture
Patients (12 years or older) whose parents are unable to understand informed consent
Patients (12 years or older) or parents who are unable to fill out questionnaires
Patients (12 years or older) or parents who are unable to understand treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary end-point will be ankle dorsiflexion. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary end-point will be satisfaction, walking pattern, pain, complications,<br /><br>activity level and foot pressure. Functional outcome will be measured by:<br /><br>AOFAS-score and functional mobility scale (FMS).</p><br>
© Copyright 2025. All Rights Reserved by MedPath